Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, Ten Dijke P, Borovecki F, Markwalder R, Thalmann GN, Papapoulos SE, Pelger RC, Vukicevic S, Cecchini MG, Löwik CW, van der Pluijm G. Buijs JT, et al. Am J Pathol. 2007 Sep;171(3):1047-57. doi: 10.2353/ajpath.2007.070168. Am J Pathol. 2007. PMID: 17724140 Free PMC article.
CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Zoni E, Chen L, Karkampouna S, Granchi Z, Verhoef EI, La Manna F, Kelber J, Pelger RCM, Henry MD, Snaar-Jagalska E, van Leenders GJLH, Beimers L, Kloen P, Gray PC, van der Pluijm G, Kruithof-de Julio M. Zoni E, et al. Among authors: pelger rcm. Oncogene. 2017 Aug 17;36(33):4739-4749. doi: 10.1038/onc.2017.87. Epub 2017 Apr 10. Oncogene. 2017. PMID: 28394345 Free PMC article.
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer.
van der Horst G, van de Merbel AF, Ruigrok E, van der Mark MH, Ploeg E, Appelman L, Tvingsholm S, Jäätelä M, van Uhm J, Kruithof-de Julio M, Thalmann GN, Pelger RCM, Bangma CH, Boormans JL, van der Pluijm G, Zwarthoff EC. van der Horst G, et al. Among authors: pelger rcm. Mol Oncol. 2020 Dec;14(12):3121-3134. doi: 10.1002/1878-0261.12793. Epub 2020 Oct 16. Mol Oncol. 2020. PMID: 32896947 Free PMC article.
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.
La Manna F, De Menna M, Patel N, Karkampouna S, De Filippo MR, Klima I, Kloen P, Beimers L, Thalmann GN, Pelger RCM, Jacinto E, Kruithof-de Julio M. La Manna F, et al. Among authors: pelger rcm. Front Oncol. 2021 Feb 3;11:650623. doi: 10.3389/fonc.2021.650623. eCollection 2021. Front Oncol. 2021. PMID: 33614519 Free PMC article.
126 results